Hereditary non-polyposis colorectal cancer (HNPCC) is characterised by a genetic predisposition to develop colorectal cancer at an early age and, to a lesser degree, cancer of the endometrium, ovaries, urinary tract, and organs ofthe gastrointestinal tract other than the colon. In the majority offamilies the disease is linked to mutations in one of the two mismatch repair genes, hMSH2 or hMLH1. We have found a novel hMLH1 nonsense mutation in a Swiss family with Lynch syndrome, which has been transmitted through at least nine generations. A different tumour spectrum of neoplasms of the skin, soft palate, breast, duodenum, and pancreas was observed in three branches of this family, where there was a virtual absence of colonic tumours. The hMLH1 mutation could not be detected in members of these branches suggesting that at least a second genetic defect predisposing to cancer is segregating in part of the kindred.
Recently, heterozygous germline mutations in any one of the four mismatch repair gene homologues, hMSH2, hMLHl, hPMS1, and hPMS2, have been shown to be linked to HNPCC.5-9 Germline mutations in hMSH2 and hMLHl appear to account for the majority of HNPCC families.0-" The products of these genes are involved in the process of mismatch repair (MMR) by recognising base-base mismatches and unpaired loops, before excising and replacing them with the correct nucleotides. '" Evidence suggests that the second wild type copy of the relevant mismatch repair gene is inactivated in HNPCC tumour cells. 14 A remarkable feature of tumour DNA isolated from HNPCC patients is its overall genomic instability, reflecting a mismatch repair deficiency. This phenotype is easily detected as shifts in the electrophoretic mobility of microsatellite DNA sequences containing di-and trinucleotide repeats. 15-17 Several studies have shown that genomic instability is not restricted to HNPCC, as it is also observed in a substantial proportion of the early onset sporadic forms of colorectal cancer.' 8 19 Here we report a mutation analysis in a large family showing an unusual tumour spectrum, with typical manifestations of HNPCC in at least two of its branches but almost exclusively extracolonic tumours in three other branches. In the HNPCC subfamilies of the kindred the causative mutation identified is a G-*A germline transition in the hMLH 1 and T4 polynucleotide kinase. Following PCR, 1-3 p1 of reaction product were denatured and electrophoresed on denaturing 8% polyacrylamide gels (Accugel 19:1 from National Diagnostics/ Atlanta). After electrophoresis, the gels were dried and exposed to x ray films for 12-18 hours. The same experimental conditions were used to amplify the markers D3S1277 and D3S161 1, linked to the hMLHl gene.
ANALYSIS OF CDNA Total RNA was extracted from 100 pl of fresh blood using Catrimox-14 (Iowa Biotechnology Corp), and cDNA was generated using random hexamers and reverse transcriptase from Gibco/BRL. A two step PCR using nested primers was used to amplify the hMLH 1 transcript in two overlapping fragments. Fragment A contained part of the 5' UTR and codons 1-394 and fragment B contained codons 325 to the termination codon (756), and part of the 3' UTR.
IN VITRO SYNTHESISED PROTEIN ASSAY (IVSP)
The above products were used as templates for a nested PCR with a 5' end modified primer that included signals for transcription by T7 polymerase and a eukaryotic consensus sequence for in vitro coupled transcriptiontranslation (IVSP), in a volume of 25 p1,20 using 2 p1 of ['H] leucine (Amersham). The products of translation were separated on SDS-12.5% polyacrylamide gels (Protogel, National Diagnostics/Atlanta), which were then dried and subjected to autoradiography. Bo, bone; Br, breast; Ce, caecum; Co, colon; Csu, cancer site unknown; Dn, duodenum; Gli, glioblastoma; Ki, kidney; Ov, ovary; Pa, soft palate; Lu, lung; Si, sigmoid; Sk, skin; St, stomach; Tr, transverse colon. Subjects with a plus were identified as carriers of the nonsense mutation at codon 714 of the hMLHI gene, whereas subjects with a minus are not carriers.
SEQUENCE ANALYSIS
Sequence analysis was carried out either from products of RT-PCR or from products of PCR from genomic DNA. When necessary these products were purified using a QIAquick PCR purification kit (Qiagen, Germany). Sequencing was performed with SequiTherm Polymerase (Epicentre Technologies, Madison, WI), using primers labelled at their 5' end with T4 polynucleotide kinase, following the conditions specified by the manufacturer. Alternatively, genomic sequencing was also performed as previously described.2' DNA templates from people in whom the mutation reported in this paper was searched for were sequenced in both directions, and results were confirmed by sequencing at least two independent PCR products. Sequences of all primers used for microsatellite amplification, IVSP, and sequencing are available upon request from PH (e-mail: pierre.hutter@ichv.vsnet.ch).
Results
The kindred described here comes from an alpine region in southern Switzerland and has previously attracted medical attention.22 New inquiries allowed us to extend the pedigree, as shown in fig 1, and medical records now document a high incidence of colorectal cancer for the last six generations. In search for a possible HNPCC mutation, all exons and exon/intron boundaries of the hMSH2 and hMLH1 genes of patient III.25 were sequenced from genomic DNA. Two polymorphisms were observed, an already reported A to G transition in hMSH2 at nucleotide + 9 of the donor splice site of intron 10 and a novel G to A transition in hMLH1 at nucleotide + 11 of the donor splice site of intron 13. Apart from these polymorphisms a heterozygous G to A transition was detected in exon In order to determine whether we were dealing with two independent events, allele specific markers were used to compare the chromosomal background of the two patients. For this purpose we compared the size of two polymorphic microsatellites, D3S 1277 and D3S 161 1, which had been used for the original linkage analysis of the hMLH1 gene. D3S1277 is located close to this gene and D3S1611 lies within it.8 23 The results indicated that a recombination event had occurred between marker D3S 1277 and the above nucleotide 2182 but that the intragenic marker D3S 1611 was identical, suggesting that it was inherited from a common ancestor (fig 4) . In order to show that the mutation cosegregated with the disease, the entire exon 19 was sequenced from genomic DNA of 41 other members of the kindred (fig 1) . The same germline mutation was found in all seven patients who had presented with an early onset cancer and in four > , 27, 46, and 51 ion for the latter subjects did not mours related to branches, suggesting that the mutation did not spread to branches A, B, and probably C of the kindred under study.
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